Search Results

PF-562271 besylate 50 mg  | 99.50%

TargetMol

PF-562271 (besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.

More Information Supplier Page

PF-562271 besylate 2 mg  | 99.50%

TargetMol

PF-562271 (besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.

More Information Supplier Page

QNZ 10 mg  | 99.17%

TargetMol

QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.

More Information Supplier Page

QNZ 25 mg  | 99.17%

TargetMol

QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.

More Information Supplier Page

QNZ 5 mg  | 99.17%

TargetMol

QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.

More Information Supplier Page

QNZ 50 mg  | 99.17%

TargetMol

QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.

More Information Supplier Page